Quell

Developer of engineered regulatory T cell therapies for immune diseases

placeLondon, England, United Kingdom calendar_todayFounded 2019 groups18 employees language quell-tx.com

Registered entities

Social engagement

Social engagement: 20.8K social following, 8 posts in the last 12 months — around the industry typical range.

Investor mix

19 investors on record; lead investors include Ridgeback Capital Management, SV Health Investors, Fidelity Investments, Syncona.

Investor typeCountShare
Venture capital737%
Private equity211%
Other / undisclosed1053%

Recent activity

24 Jun 2026
Milestone
regulatory
10 Jun 2026
Event
FOCIS 2026 Annual Meeting
3 Jun 2026
Event
EULAR - European Alliance of Associations for Rheumatology
Coming soon